These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 2605696)
1. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. II. Application of reduced pressure treatment for the improvement of dissolution of flufenamic acid. Konno T; Kinuno K Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2481-4. PubMed ID: 2605696 [TBL] [Abstract][Full Text] [Related]
2. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. IV. Study on reduced-pressure mixing for practical use of amorphous mixtures of flufenamic acid. Konno T Chem Pharm Bull (Tokyo); 1990 Jul; 38(7):2003-7. PubMed ID: 2268904 [TBL] [Abstract][Full Text] [Related]
3. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. III. Determination of vapor pressure of solid drugs by steam distillation. Konno T Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1032-4. PubMed ID: 2379275 [TBL] [Abstract][Full Text] [Related]
4. Dissolution Behavior of Flufenamic Acid in Heated Mixtures with Nanocellulose. Mantas A; Mihranyan A Molecules; 2020 Mar; 25(6):. PubMed ID: 32168901 [TBL] [Abstract][Full Text] [Related]
5. Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution. Guo M; Wang K; Qiao N; Fábián L; Sadiq G; Li M Mol Pharm; 2017 Dec; 14(12):4583-4596. PubMed ID: 29091446 [TBL] [Abstract][Full Text] [Related]
6. Influence of the microwave technology on solid dispersions of mefenamic acid and flufenamic acid. Alshehri S; Shakeel F; Ibrahim M; Elzayat E; Altamimi M; Shazly G; Mohsin K; Alkholief M; Alsulays B; Alshetaili A; Alshahrani A; Almalki B; Alanazi F PLoS One; 2017; 12(7):e0182011. PubMed ID: 28759638 [TBL] [Abstract][Full Text] [Related]
7. Solid dispersion adsorbate technique for improved dissolution and flow properties of lurasidone hydrochloride: characterization using 3 Mahajan A; Surti N; Koladiya P Drug Dev Ind Pharm; 2018 Mar; 44(3):463-471. PubMed ID: 29098883 [TBL] [Abstract][Full Text] [Related]
8. Quantitative study of solid-state acid-base reactions between polymorphs of flufenamic acid and magnesium oxide using X-ray powder diffraction. Chen X; Stowell JG; Morris KR; Byrn SR J Pharm Biomed Anal; 2010 Mar; 51(4):866-74. PubMed ID: 19906502 [TBL] [Abstract][Full Text] [Related]
9. Influence of wetting factors on the dissolution behavior of flufenamic acid. Itai S; Nemoto M; Kouchiwa S; Murayama H; Nagai T Chem Pharm Bull (Tokyo); 1985 Dec; 33(12):5464-73. PubMed ID: 3833390 [No Abstract] [Full Text] [Related]
10. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
11. Physical and chemical changes of medicinals in mixtures with adsorbents in the solid state. I. Effect of vapor pressure of the medicinals on changes in crystalline properties. Konno T; Kinuno K; Kataoka K Chem Pharm Bull (Tokyo); 1986 Jan; 34(1):301-7. PubMed ID: 3698136 [No Abstract] [Full Text] [Related]
12. Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil. Wlodarski K; Sawicki W; Haber K; Knapik J; Wojnarowska Z; Paluch M; Lepek P; Hawelek L; Tajber L Eur J Pharm Biopharm; 2015 Aug; 94():106-15. PubMed ID: 25998701 [TBL] [Abstract][Full Text] [Related]
13. Investigating Permeation Behavior of Flufenamic Acid Cocrystals Using a Dissolution and Permeation System. Guo M; Wang K; Qiao N; Yardley V; Li M Mol Pharm; 2018 Sep; 15(9):4257-4272. PubMed ID: 30080976 [TBL] [Abstract][Full Text] [Related]
14. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers. Sun DD; Lee PI J Control Release; 2015 Aug; 211():85-93. PubMed ID: 26054795 [TBL] [Abstract][Full Text] [Related]
15. The role of the polymer matrix in solvent-free hot melt extrusion continuous process for mechanochemical synthesis of pharmaceutical cocrystal. Gajda M; Nartowski KP; Pluta J; Karolewicz B Eur J Pharm Biopharm; 2018 Oct; 131():48-59. PubMed ID: 30205892 [TBL] [Abstract][Full Text] [Related]
16. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying. Parikh T; Sandhu HK; Talele TT; Serajuddin AT Pharm Res; 2016 Jun; 33(6):1456-71. PubMed ID: 26951566 [TBL] [Abstract][Full Text] [Related]
18. Dissolution behavior of co-amorphous amino acid-indomethacin mixtures: The ability of amino acids to stabilize the supersaturated state of indomethacin. Ojarinta R; Heikkinen AT; Sievänen E; Laitinen R Eur J Pharm Biopharm; 2017 Mar; 112():85-95. PubMed ID: 27888143 [TBL] [Abstract][Full Text] [Related]
19. Solvent change co-precipitation with hydroxypropyl methylcellulose phthalate to improve dissolution characteristics of a poorly water-soluble drug. Sertsou G; Butler J; Hempenstall J; Rades T J Pharm Pharmacol; 2002 Aug; 54(8):1041-7. PubMed ID: 12195817 [TBL] [Abstract][Full Text] [Related]
20. Pharmaceutical Co-Crystal of Flufenamic Acid: Synthesis and Characterization of Two Novel Drug-Drug Co-Crystal. Nechipadappu SK; Tekuri V; Trivedi DR J Pharm Sci; 2017 May; 106(5):1384-1390. PubMed ID: 28185907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]